These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36680673)

  • 1. Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions.
    Brothers L; Malhotra J; Andrews C; Smith SR
    Curr Oncol Rep; 2023 Mar; 25(3):145-150. PubMed ID: 36680673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in prevention and treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Toubai T; Hosokawa Y
    Rinsho Ketsueki; 2024; 65(5):401-411. PubMed ID: 38825520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Outcomes of Acute Inpatient Rehabilitation in Patients With Chronic Graft-Versus-Host Disease.
    Leung J; Smith S; Kalpakjian C
    PM R; 2018 Jun; 10(6):567-572. PubMed ID: 29141183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.
    Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES
    J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances and research progress in biomarkers for chronic graft versus host disease.
    Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
    Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-
    Bos S; Murray J; Marchetti M; Cheng GS; Bergeron A; Wolff D; Sander C; Sharma A; Badawy SM; Peric Z; Piekarska A; Pidala J; Raj K; Penack O; Kulkarni S; Beestrum M; Linke A; Rutter M; Coleman C; Tonia T; Schoemans H; Stolz D; Vos R
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38485149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
    Kim DDH; Popradi G; Lepic K; Paulson K; Allan D; Nampoothiri RV; Lachance S; Deotare U; White J; Elemary M; Jamani K; Fraga C; Lemieux C; Novitzky-Basso I; Law AD; Kumar R; Walker I; Schultz KR;
    Curr Oncol; 2024 Mar; 31(3):1426-1444. PubMed ID: 38534941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic graft-versus-host disease in pediatric patients: Differences and challenges.
    Haroun E; Agrawal K; Leibovitch J; Kassab J; Zoghbi M; Dutta D; Lim SH
    Blood Rev; 2023 Jul; 60():101054. PubMed ID: 36805299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care.
    Cazeau N; Rodriguez S
    Clin J Oncol Nurs; 2023 May; 27(3):259-265. PubMed ID: 37267484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
    Spałek A; Grygoruk-Wiśniowska I; Gruenpeter K; Panz-Klapuch M; Helbig G
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehabilitation in Chronic Graft-Versus-Host Disease.
    Smith SR; Asher A
    Phys Med Rehabil Clin N Am; 2017 Feb; 28(1):143-151. PubMed ID: 27912993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation.
    Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H
    Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Treatment of Chronic Graft-versus-Host Disease Post-Allogeneic Hematopoietic Cell Transplantation: A US Claims Analysis.
    Bachier CR; Aggarwal SK; Hennegan K; Milgroom A; Francis K; Dehipawala S; Rotta M
    Transplant Cell Ther; 2021 Jun; 27(6):504.e1-504.e6. PubMed ID: 34158154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis and Therapeutic Prospects of Chronic Graft-Versus-Host Disease --Review].
    Xu SH; Man Y; Zhao JL; Wang YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):647-652. PubMed ID: 38660881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of steroid-responsive but dependent chronic graft-versus-host disease: a multicenter retrospective analysis.
    Oyama T; Matsuda K; Honda A; Maki H; Masamoto Y; Murakami D; Toya T; Sakurai M; Kataoka K; Doki N; Kurokawa M
    Int J Hematol; 2023 Feb; 117(2):260-268. PubMed ID: 36251231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
    Logan BR; Fu D; Howard A; Fei M; Kou J; Little MR; Adom D; Mohamed FA; Blazar BR; Gafken PR; Paczesny S
    J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37526081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
    Diep PP; Rueegg CS; Burman MM; Brinch L; Bø K; Fosså K; Landrø L; Loge JH; Lund MB; Massey RJ; Myrdal OH; Pathak M; Rimstad L; Tanem KE; Tjønnfjord GE; Aaløkken TM; Ruud E
    J Adolesc Young Adult Oncol; 2023 Feb; 12(1):66-75. PubMed ID: 35544321
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia.
    Lv M; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Med; 2019 Dec; 13(6):667-679. PubMed ID: 31512033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.